A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ELAB SEC filings page.
PMGC Holdings Inc. (ELAB) reported $590K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Shrinking sales now sit beneath a loss-making structure, while external financing remains central to funding the business's cash needs.
From FY2023 to FY2025, revenue fell from$1.7M to$590K , shrinking the pool available to support the cost base. Over that span, gross margin compressed from66.3% to31.4% , so the remaining sales generated less contribution before overhead rather than merely reflecting lower volume.
FY2025 financing provided
Liabilities increased between FY2023 and FY2025 while the current ratio fell from 3.8x to 1.7x; short-term flexibility narrowed as obligations grew. The supplied liquidity measure was 12.1 months of reported annual operating outflow, adding context to the funding picture without changing its financing-led character.
Financial Health Signals
PMGC Holdings Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
PMGC Holdings Inc. passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
PMGC Holdings Inc. reported a net loss of $7.7M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
PMGC Holdings Inc. generated $1.3M in revenue in Q2 2026. Against the prior quarter it is up 91.6%.
PMGC Holdings Inc. reported a net loss of $2.9M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q2 2026.
Cash & Balance Sheet
PMGC Holdings Inc. recorded an outflow of $2.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
PMGC Holdings Inc. held $18.1M in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Margins & Returns
PMGC Holdings Inc.'s gross margin was 29.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. Against the prior quarter it is down 4.3 percentage points.
PMGC Holdings Inc.'s quarterly ROE was -17.6% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 11.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 21.8 percentage points.
Not reported for Q2 2026.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
PMGC Holdings Inc. invested $310K in research and development in Q2 2026. This represents an increase of 365.3% from the same quarter a year earlier. Against the prior quarter it is up 559.2%.
PMGC Holdings Inc. invested $28K in capex in Q2 2026, funding long-term assets and infrastructure. Against the prior quarter it is down 92.4%.
Not reported for Q2 2026.
ELAB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $682K | N/A | $286K-45.8% | N/A | N/A | N/A | $527K-4.9% |
| Cost of Revenue | $921K | $452K | N/A | $208K+55.7% | N/A | N/A | N/A | $134K-99.9% |
| Gross Profit | $386K | $230K | N/A | $78K-80.2% | N/A | N/A | N/A | $394Kn/m |
| R&D Expenses | $310K+365.3% | $47K+45.1% | N/A | $15K+266.0% | $67K+91.5% | $32K+1065.8% | N/A | $4K-95.3% |
| SG&A Expenses | $1.6M+401.9% | $1.4M+561.0% | N/A | $727K+334.9% | $320K-63.2% | $209K-60.2% | N/A | $167K-99.8% |
| Operating Income | N/A | N/A | N/A | -$2.2Mn/m | N/A | N/A | N/A | -$626Kn/m |
| EBITDA | N/A | N/A | N/A | -$2.2Mn/m | N/A | N/A | N/A | -$625Kn/m |
| Interest Expense | $582K+29111950.0% | $184K+1660.5% | N/A | $17K-97.3% | $2-100.0% | $10K-45.4% | N/A | $642K-88.8% |
| Net Income | -$2.9Mn/m | -$5.0Mn/m | N/A | -$2.6Mn/m | -$562Kn/m | -$1.6Mn/m | N/A | -$1.5Mn/m |
| EPS (Basic) | -$0.61 | -$11.22 | N/A | -$4.95 | -$39.14 | -$243.76 | N/A | -$0.07 |
| EPS (Diluted) | -$0.61 | -$11.22 | N/A | -$4.95 | -$39.14 | -$243.76 | N/A | -$0.07 |
Not reported in any period shown, so not listed: Income Tax, Diluted Shares (Avg).
ELAB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $36.6M+290.0% | $26.0M+192.9% | $12.9M+43.1% | $14.9M+33.3% | $9.4M+84.5% | $8.9M+110.3% | $9.0M+73.3% | $11.2M-99.3% |
| Current Assets | $20.8M+185.3% | $16.4M+140.4% | $6.9M+13.6% | $9.8M+18.8% | $7.3M+259.6% | $6.8M+117.0% | $6.1M+23.0% | $8.2M-99.4% |
| Cash & Equivalents | $18.1M+219.2% | $14.4M+167.6% | $5.4M+35.6% | $7.7M+19.8% | $5.7M+5580.7% | $5.4M+468.4% | $4.0M+19.8% | $6.4M+1247.5% |
| Short-Term Investments | $651K+4.1% | $733K+31.6% | $572Kn/m | $804Kn/m | $625Kn/m | $557Kn/m | $0n/m | $0n/m |
| Inventory | $933K | $254K | $95K | $128K-87.0% | N/A | N/A | N/A | $986K-99.8% |
| Long-Term Investments | $0n/m | $0n/m | N/A | $0n/m | $0n/m | $0n/m | $139Kn/m | $0n/m |
| Goodwill | $3.0M | $1.9M | $978K | $960K | N/A | N/A | N/A | N/A |
| Total Liabilities | $19.8M+5976.5% | $13.4M+1666.1% | $5.0M+115.6% | $6.4M+143.3% | $326K-86.6% | $760K-56.3% | $2.3M+71.2% | $2.7M-99.8% |
| Current Liabilities | $15.3M+4597.7% | $11.3M+1386.0% | $3.9M+119.1% | $5.5M+156.4% | $326K-83.1% | $760K-37.8% | $1.8M+38.7% | $2.1M-99.9% |
| Non-Current Liabilities | $4.5Mn/m | $2.1Mn/m | $1.1M+103.7% | $986K+89.7% | $0-100.0% | $0-100.0% | $534K+716.1% | $520K-99.5% |
| Total Equity | $16.7M+85.0% | $12.6M+55.1% | $7.8M+17.7% | $8.5M-0.8% | $9.0M+242.8% | $8.1M+226.9% | $6.7M+74.0% | $8.6Mn/m |
| Retained Earnings | -$28.9Mn/m | -$26.0Mn/m | -$21.0Mn/m | -$18.0Mn/m | -$15.4Mn/m | -$14.9Mn/m | -$13.3Mn/m | -$11.3Mn/m |
Not reported in any period shown, so not listed: Accounts Receivable, Long-Term Debt.
ELAB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.0Mn/m | -$3.0Mn/m | -$1.8Mn/m | -$1.5Mn/m | -$1.3Mn/m | -$1.3Mn/m | -$2.0Mn/m | -$382Kn/m |
| Depreciation & Amortization | $281K+1406085.0% | $159K+14595.3% | $60K+44494.0% | $35K+25844.1% | $20-85.7% | $1K-94.0% | $134-96.5% | $136-94.4% |
| Stock-Based Compensation | N/A | $8Kn/m | N/A | N/A | N/A | -$59K-206.3% | N/A | N/A |
| Capital Expenditures | -$28K | $363K | $347Kn/m | N/A | N/A | N/A | $0n/m | $0n/m |
| Free Cash Flow | -$2.0M | -$3.3M | -$2.1Mn/m | N/A | N/A | N/A | -$2.0Mn/m | -$382Kn/m |
| Investing Cash Flow | -$3.7M-1972.0% | -$2.5Mn/m | -$549Kn/m | -$2.2Mn/m | $197Kn/m | -$215Kn/m | -$439Kn/m | -$50Kn/m |
| Financing Cash Flow | $9.5M+544.6% | $14.4M+389.7% | -$1n/m | $5.7M | $1.5M | $2.9M | -$1-100.0% | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
ELAB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.5% | 33.8% | N/A | 27.3%-47.4pp | N/A | N/A | N/A | 74.7% |
| Operating Margin | N/A | N/A | N/A | -769.0% | N/A | N/A | N/A | -118.6% |
| Net Margin | -225.1% | -728.3% | N/A | -907.3% | N/A | N/A | N/A | -284.6% |
| Return on Equity | -17.6%-11.4pp | -39.4%-19.6pp | N/A | -30.6%-13.0pp | -6.2%+47.3pp | -19.8%+36.4pp | N/A | -17.5% |
| Return on Assets | -8.0%-2.0pp | -19.1%-1.0pp | N/A | -17.4%-4.0pp | -6.0%+21.8pp | -18.1%+15.0pp | N/A | -13.4%-13.4pp |
| Current Ratio | 1.36-21.0x | 1.45-7.5x | 1.74-1.6x | 1.79-2.1x | 22.38+21.3x | 8.97+6.4x | 3.36-0.4x | 3.86+3.1x |
| Liabilities-to-Equity | 1.18+1.1x | 1.07+1.0x | 0.64+0.3x | 0.76+0.4x | 0.04-0.9x | 0.09-0.6x | 0.350.0x | 0.31 |
| Asset Turnover | 0.04 | 0.03 | N/A | 0.020.0x | N/A | N/A | N/A | 0.050.0x |
| FCF Margin | -154.2% | -490.1% | N/A | N/A | N/A | N/A | N/A | -72.4%+20.4pp |
Not reported in any period shown, so not listed: Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| PMGC Holdings Inc. ELAB | FY2025 | $590K | -$7.7M | N/A | $2.2M | — |
| SciSparc Ltd. SPRC | FY2025 | $856K | -$12.6M | N/A | $697K | — |
| Revelation Biosciences, Inc. REVB | FY2025 | N/A | -$8.9M | N/A | $2.1M | — |
| Indaptus Therapeutics, Inc. INDP | FY2025 | N/A | -$20.8M | N/A | $398.4M | — |
Where PMGC Holdings Inc. Ranks
Frequently Asked Questions
What is PMGC Holdings Inc.'s annual revenue?
PMGC Holdings Inc. (ELAB) reported $590K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is PMGC Holdings Inc. profitable?
No, PMGC Holdings Inc. (ELAB) reported a net loss of $7.7M in fiscal year 2025.
What is PMGC Holdings Inc.'s gross margin?
PMGC Holdings Inc. (ELAB) had a gross margin of 31.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is PMGC Holdings Inc.'s return on equity (ROE)?
PMGC Holdings Inc. (ELAB) has a return on equity of -98.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is PMGC Holdings Inc.'s free cash flow?
PMGC Holdings Inc. (ELAB) recorded an outflow of $6.4M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is PMGC Holdings Inc.'s operating cash flow?
PMGC Holdings Inc. (ELAB) recorded an outflow of $5.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are PMGC Holdings Inc.'s total assets?
PMGC Holdings Inc. (ELAB) had $12.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are PMGC Holdings Inc.'s capital expenditures?
PMGC Holdings Inc. (ELAB) invested $442K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does PMGC Holdings Inc. spend on research and development?
PMGC Holdings Inc. (ELAB) invested $147K in research and development during fiscal year 2025.
What is PMGC Holdings Inc.'s current ratio?
PMGC Holdings Inc. (ELAB) had a current ratio of 1.74 as of fiscal year 2025, which is generally considered healthy.
What is PMGC Holdings Inc.'s liabilities-to-equity ratio?
PMGC Holdings Inc. (ELAB) had a liabilities-to-equity ratio of 0.64 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is PMGC Holdings Inc.'s return on assets (ROA)?
PMGC Holdings Inc. (ELAB) had a return on assets of -60.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is PMGC Holdings Inc.'s P/E ratio?
PMGC Holdings Inc. (ELAB) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $2.2M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is PMGC Holdings Inc.'s price-to-sales ratio?
PMGC Holdings Inc. (ELAB) trades at 3.7x sales, its market capitalization divided by $590K revenue, FY2025. The market capitalization is $2.2M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is PMGC Holdings Inc.'s Piotroski F-Score?
PMGC Holdings Inc. (ELAB) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are PMGC Holdings Inc.'s earnings high quality?
PMGC Holdings Inc. (ELAB) reported a net loss of $7.7M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.